Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences: Comparison of T1, T2*, and synergistic T1 - T2* contrast mechanisms

O. M. Girard, J. Du, L. Agemy, K. N. Sugahara, V. R. Kotamraju, E. Ruoslahti, G. M. Bydder, R. F. Mattrey

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Iron oxide nanoparticles (IONPs) are used in various MRI applications as negative contrast agents. A major challenge is to distinguish regions of signal void due to IONPs from those due to low signal tissues or susceptibility artifacts. To overcome this limitation, several positive contrast strategies have been proposed. Relying on IONP T1 shortening effects to generate positive contrast is a particularly appealing strategy because it should provide additional specificity when associated with the usual negative contrast from effective transverse relaxation time (T2) effects. In this article, ultrashort echo time imaging is shown to be a powerful technique which can take full advantage of both contrast mechanisms. Methods of comparing T 1 and T2* contrast efficiency are described and general rules that allow optimizing IONP detection sensitivity are derived. Contrary to conventional wisdom, optimizing T1 contrast is often a good strategy for imaging IONPs. Under certain conditions, subtraction of a later echo signal from the ultrashort echo time signal not only improves IONP specificity by providing long T2* background suppression but also increases detection sensitivity, as it enables a synergistic combination of usually antagonist T1 and T2* contrasts. In vitro experiments support our theory, and a molecular imaging application is demonstrated using tumor-targeted IONPs in vivo.

Original languageEnglish (US)
Pages (from-to)1649-1660
Number of pages12
JournalMagnetic Resonance in Medicine
Volume65
Issue number6
DOIs
StatePublished - Jun 1 2011

Fingerprint

Nanoparticles
Molecular Imaging
ferric oxide
Artifacts
Contrast Media
Neoplasms

Keywords

  • iron oxide nanoparticle
  • positive contrast
  • sequence optimization
  • UTE

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences : Comparison of T1, T2*, and synergistic T1 - T2* contrast mechanisms. / Girard, O. M.; Du, J.; Agemy, L.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E.; Bydder, G. M.; Mattrey, R. F.

In: Magnetic Resonance in Medicine, Vol. 65, No. 6, 01.06.2011, p. 1649-1660.

Research output: Contribution to journalArticle

Girard, O. M. ; Du, J. ; Agemy, L. ; Sugahara, K. N. ; Kotamraju, V. R. ; Ruoslahti, E. ; Bydder, G. M. ; Mattrey, R. F. / Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences : Comparison of T1, T2*, and synergistic T1 - T2* contrast mechanisms. In: Magnetic Resonance in Medicine. 2011 ; Vol. 65, No. 6. pp. 1649-1660.
@article{c61ede9bb91e4210865d5e7ce9cc302f,
title = "Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences: Comparison of T1, T2*, and synergistic T1 - T2* contrast mechanisms",
abstract = "Iron oxide nanoparticles (IONPs) are used in various MRI applications as negative contrast agents. A major challenge is to distinguish regions of signal void due to IONPs from those due to low signal tissues or susceptibility artifacts. To overcome this limitation, several positive contrast strategies have been proposed. Relying on IONP T1 shortening effects to generate positive contrast is a particularly appealing strategy because it should provide additional specificity when associated with the usual negative contrast from effective transverse relaxation time (T2) effects. In this article, ultrashort echo time imaging is shown to be a powerful technique which can take full advantage of both contrast mechanisms. Methods of comparing T 1 and T2* contrast efficiency are described and general rules that allow optimizing IONP detection sensitivity are derived. Contrary to conventional wisdom, optimizing T1 contrast is often a good strategy for imaging IONPs. Under certain conditions, subtraction of a later echo signal from the ultrashort echo time signal not only improves IONP specificity by providing long T2* background suppression but also increases detection sensitivity, as it enables a synergistic combination of usually antagonist T1 and T2* contrasts. In vitro experiments support our theory, and a molecular imaging application is demonstrated using tumor-targeted IONPs in vivo.",
keywords = "iron oxide nanoparticle, positive contrast, sequence optimization, UTE",
author = "Girard, {O. M.} and J. Du and L. Agemy and Sugahara, {K. N.} and Kotamraju, {V. R.} and E. Ruoslahti and Bydder, {G. M.} and Mattrey, {R. F.}",
year = "2011",
month = "6",
day = "1",
doi = "10.1002/mrm.22755",
language = "English (US)",
volume = "65",
pages = "1649--1660",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Optimization of iron oxide nanoparticle detection using ultrashort echo time pulse sequences

T2 - Comparison of T1, T2*, and synergistic T1 - T2* contrast mechanisms

AU - Girard, O. M.

AU - Du, J.

AU - Agemy, L.

AU - Sugahara, K. N.

AU - Kotamraju, V. R.

AU - Ruoslahti, E.

AU - Bydder, G. M.

AU - Mattrey, R. F.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Iron oxide nanoparticles (IONPs) are used in various MRI applications as negative contrast agents. A major challenge is to distinguish regions of signal void due to IONPs from those due to low signal tissues or susceptibility artifacts. To overcome this limitation, several positive contrast strategies have been proposed. Relying on IONP T1 shortening effects to generate positive contrast is a particularly appealing strategy because it should provide additional specificity when associated with the usual negative contrast from effective transverse relaxation time (T2) effects. In this article, ultrashort echo time imaging is shown to be a powerful technique which can take full advantage of both contrast mechanisms. Methods of comparing T 1 and T2* contrast efficiency are described and general rules that allow optimizing IONP detection sensitivity are derived. Contrary to conventional wisdom, optimizing T1 contrast is often a good strategy for imaging IONPs. Under certain conditions, subtraction of a later echo signal from the ultrashort echo time signal not only improves IONP specificity by providing long T2* background suppression but also increases detection sensitivity, as it enables a synergistic combination of usually antagonist T1 and T2* contrasts. In vitro experiments support our theory, and a molecular imaging application is demonstrated using tumor-targeted IONPs in vivo.

AB - Iron oxide nanoparticles (IONPs) are used in various MRI applications as negative contrast agents. A major challenge is to distinguish regions of signal void due to IONPs from those due to low signal tissues or susceptibility artifacts. To overcome this limitation, several positive contrast strategies have been proposed. Relying on IONP T1 shortening effects to generate positive contrast is a particularly appealing strategy because it should provide additional specificity when associated with the usual negative contrast from effective transverse relaxation time (T2) effects. In this article, ultrashort echo time imaging is shown to be a powerful technique which can take full advantage of both contrast mechanisms. Methods of comparing T 1 and T2* contrast efficiency are described and general rules that allow optimizing IONP detection sensitivity are derived. Contrary to conventional wisdom, optimizing T1 contrast is often a good strategy for imaging IONPs. Under certain conditions, subtraction of a later echo signal from the ultrashort echo time signal not only improves IONP specificity by providing long T2* background suppression but also increases detection sensitivity, as it enables a synergistic combination of usually antagonist T1 and T2* contrasts. In vitro experiments support our theory, and a molecular imaging application is demonstrated using tumor-targeted IONPs in vivo.

KW - iron oxide nanoparticle

KW - positive contrast

KW - sequence optimization

KW - UTE

UR - http://www.scopus.com/inward/record.url?scp=79958256467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958256467&partnerID=8YFLogxK

U2 - 10.1002/mrm.22755

DO - 10.1002/mrm.22755

M3 - Article

C2 - 21305596

AN - SCOPUS:79958256467

VL - 65

SP - 1649

EP - 1660

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 6

ER -